Ligand · 6LV
6LV · 5-(3,5-dimethoxybenzyl)[1,2,4]triazolo[1,5-c]quinazolin-2-amine
6LV, 5-(3,5-dimethoxybenzyl)[1,2,4]triazolo[1,5-c]quinazolin-2-amine (C18 H17 N5 O2, 335.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it…
- Component
- 6LV
- Formula
- C18 H17 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
6LV in 2 structures; the first of them:
- 4CWN · Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor · 6LV A1224 · binds ASN51, SER52, ALA55, ASP93, ILE96, GLY97, MET98, ASP102 and 8 more
- 4CWN · Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor · 6LV A1224 · binds ASN51, SER52, ALA55, ASP93, ILE96, GLY97, MET98, ASP102 and 8 more
Residues it binds most
ALA 2, ASP 2, LEU 2, ASN 2, GLY 2, ILE 2, MET 2, PHE 2, SER 2, THR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.